Abstract
Diabetic retinopathy (DR) is a potentially blinding complication of diabetes mellitus. After the initial diagnosis of diabetes, the deficiencies typical for DR, namely abnormal autoregulation of retinal arteries, increased blood flow, breakdown of the blood-retinal barrier, and disturbances in retinal function develop silently and remain clinically undetected for quite some time. A characteristic microangiopathy in the fundus is one of the first visible signs of DR. Macular edema, neovascularization, contraction of the vitreous and of proliferated fibrovascular tissue are late consequences in the diabetic eye. The severity of these lesions is closely related to the duration of diabetes, to blood glucose control, and to risk factors such as hypertension.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamis, A.P., 2002, Is diabetic retinopathy an inflammatory disease?Br. J. Ophthalmol 86:363.
Ambati, J., Chalam, K., Chawla, D., D’Angio, C., Guillet, E., Rose, S., Vanderlinde, R., and Ambati, B., 1997, Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.Arch. Ophthalmol. 115:1161.
Barouch, F.C., Miyamoto, K., Allprot, J.R., Fujita, K., Bursell, S.-E., Aiello, L.P., Luscinskas, F.W., and Adamis, A.P., 2000, Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.Invest. Ophthalmol Vis. Sci. 41:1153.
Bates, D.O., Hillman, N.J., Williams, B., Neal, C.R., and Pocock, T.M., 2002, Regulation of microvascular permeability by vascular endothelial growth factors.J. Anat. 200:581.
Bok, D., Senanayake, P., Calabro, A., Hu, J.G., and Hollyfield, J.G., 2002, Glycogen synthesis in human RPE. Invest. Ophthalmol. Vis. Sci. ARVO no. 4569 43:182.
Crooks, J., and Kolb, H., 1992, Localization of GABA, glycine, glutamate and tyrosine hydroxylase in the human retina.J. comp. Neurol. 315:287.
Do Carmo, A., Ramos, P., Reis, A., Proença, R., and Cunha-Vaz, J.G., 1998, Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.Exp. Eye Res.67: 569.
Dosso, A.A., Bonvin, E.R., Morel, Y., Golay, A., Assal, J.P., and Leuenberger, P.M., 1996, Risk factors with contrast sensitivity loss in diabetic patients.Graefes Arch. Clin. Exp. Ophthalmol. 234:300.
Hardy, K.J., Lipton, J., Foster, D.H., and Scarpello, J.H.B., 1992, Detection of colour vision abnormalities in uncomplicated type I diabetic patients with angiographically normal retinas.Br. J. Ophthalmol.76: 461.
Ishikawa, A., Ishiguro, S., and Tamai, M., 1996, Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas.Curr. Eye Res. 15:63.
Kalloniatis, M., and Napper, G.A., 2002, Retinal neurochemical changes following application of glutamate as a metabolic substrate.Clin. Exp. Optom. 85:27.
Kowluru, R.A., Engerman, D.L., Case, G.L., and Kern, T.S., 2001, Retinal glutamate in diabetes and effect of antioxidants.Neurochem. Int. 38:385.
Li, Q., and Pouro, D.G., 2002, Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells.Invest. Ophthalmol Vis. Sci. 43:3109.
Lieth, E., Barber, A., Xu, B., Dice, C., Ratz, M., Tanase, D., and Strother, J., 1998, Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy.Diabetes 42:815.
Lieth, E., Lanoue, K.F., Antonetti, D.A., Ratz, M., and The Penn State Retina Research Group, 2000, Diabetes reduces glutamate oxidation and glutamine synthesis in the retina.Exp. Eye Res.70: 723.
Lu, M., Perez, V.L., Naili, M., Miyamoto, K., Peng, H.-B., Liao, J.K., and Adamis, A.P., 1999, VEGF increases retinal vascular ICAM-1 expression in vivo.Invest. Ophthalmol. Vis. Sci. 40:1808.
Miyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L.P., Ogura, Y., and Adamis, A.P., 2000, Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).Am. J. Pathol. 156:1733.
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A.C., Aiello, L.P., Ogura, Y., and Adamis, A.O., 1999, Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.Proc. Natl. Acad. Sci. 96:10836.
Poitry, S., Poitry-Yamate, C., Ueberfeld, J., MacLeish, P.R., and Tsacopoulos, M., 2000, Mechanisms of glutamate metabolic signaling in retinal glial (Müller) cells. J.Neurosci. 20:1809.
Qaum, T., Xu, Q., Joussen, A.M., Clemens, M.W., Qin, W., Miyamoto, K., Hassessian, H., Wiegand, S.J., Rudge, J., Yancopoulos, G.D., and Adamis, A.P., 2001, VEGF-initiated blood-retinal barrier breakdown in early diabetes.Invest. Ophthalmol. Vis. Sci. 42:2408.
Qu, H., Eloqayli, H., Unsgard, G., and Sonnewald, U., 2001, Glutamate decreases pyruvate carboxylase activity and spares glucose as energy substrate in cultured cerebellar astrocytes.I Neurosci. Res. 66:1127.
Rungger-Brandle, E., Kolb, H., and Niemeyer, G., 1996, Histochemical demonstration of glycogen in neurons of the cat retina.Invest. Ophthalmol. Vis. Sci. 37: 702.
Rungger-Brändle, E., Dosso, A.A., and Leuenberger, P.M., 2000, Glial reactivity, an early feature of diabetic retinopathy.Invest. Ophthalmol. Vis. Sci. 41:1971.
Rybicka, K.K., 1996, Glycosomes - the organelles of glycogen metabolism.Tissue and Cell 28:253.
Takeo-Goto, S., Doi, M., Ma, N., Goto, R., Semba, R., and Uji, Y., 2002, Immunohistochemical localization of amino acids in the diabetic retina of goto-kakizaki rats.Ophthalmic Res. 34:139.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this paper
Cite this paper
Rungger-Brändle, E., Dosso, A.A. (2003). Streptozotocin-Induced Diabetes — A Rat Model to Study Involvement of Retinal Cell Types in the Onset of Diabetic Retinopathy. In: LaVail, M.M., Hollyfield, J.G., Anderson, R.E. (eds) Retinal Degenerations. Advances in Experimental Medicine and Biology, vol 533. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0067-4_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0067-4_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4909-9
Online ISBN: 978-1-4615-0067-4
eBook Packages: Springer Book Archive